Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Schuringa, Jan Jacob  [Clear All Filters]
2012
Schepers H, Wierenga ATJ, Vellenga E, Schuringa JJacob. STAT5-mediated self-renewal of normal hematopoietic and leukemic stem cells. JAKSTAT. 2012;1(1):13-22.
2016
Capala ME, Pruis M, Vellenga E, Schuringa JJacob. Depletion of SAM50 Specifically Targets BCR-ABL-Expressing Leukemic Stem and Progenitor Cells by Interfering with Mitochondrial Functions. Stem Cells Dev. 2016.
2019
Tijchon E, Yi G, Mandoli A, Smits JGA, Ferrari F, Heuts BMH, Wijnen F, Kim B, Janssen-Megens EM, Schuringa JJacob, et al. The acute myeloid leukemia associated AML1-ETO fusion protein alters the transcriptome and cellular progression in a single-oncogene expressing in vitro induced pluripotent stem cell based granulocyte differentiation model. PLoS One. 2019;14(12):e0226435.
2023
Cunningham A, Oudejans L, Geugien M, Pereira-Martins DA, Wierenga ATj, Erdem A, Sternadt D, Huls GA, Schuringa JJacob. The 'non-essential' amino acid cysteine is required to prevent ferroptosis in acute myeloid leukemia. Blood Adv. 2023.
2024
Rojas CAlexander, Pereira-Martins DAntonio, More CChristie B, Sternadt D, Weinhäuser I, Hilberink JR, Coelho-Silva JLuiz, Thomé CHassibe, Ferreira GAguiar, Ammatuna E, et al. A 4-gene prognostic index for enhancing acute myeloid leukaemia survival prediction. Br J Haematol. 2024.
Cunningham A, Oudejans LL, Geugien M, Pereira-Martins DAntonio, Wierenga ATJ, Erdem A, Sternadt D, Huls G, Schuringa JJacob. The nonessential amino acid cysteine is required to prevent ferroptosis in acute myeloid leukemia. Blood Adv. 2024;8(1):56-69.
Hof WFJ, Visser M, de Jong JJ, Rajasekar MN, Schuringa JJacob, de Graaf IAM, Touw DJ, Dekkers BGJ. Unraveling Hematotoxicity of α-Amanitin in Cultured Hematopoietic Cells. Toxins (Basel). 2024;16(1).